ಅಪರೂಪದ ರಕ್ತದ ಕ್ಯಾನ್ಸರ್ (BPDCN)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
ಎಲ್ಲಿಗೆ ಹೋಗಬೇಕು
ಈ trial ಗೆ 1 ಆಸ್ಪತ್ರೆ ರೋಗಿಗಳನ್ನು ಸೇರಿಸಿಕೊಳ್ಳುತ್ತಿದೆ.
ರಿಜಿಸ್ಟ್ರಿ ಸಾರಾಂಶ (ತಾಂತ್ರಿಕ)
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is a very rare hematologic malignancy. Despite recent advances, at present there is no consensus on the optimal treatment of BPDCN. The optimal therapy of disease remains to be determined, and due to the rarity of cases, there is a need for international collaboration to collect data on BPDCN clinical presentations, diagnostics, treatment regimens and outcomes. Therefore, the objectives of this study are: (1) to build a large database of patients with BPDCN, (2) to investigate the characteristics and outcome of the disease with different tre…
ಪ್ರಾಯೋಜಕರು: Immune Oncology Research Institute
ClinicalTrials.gov ನಲ್ಲಿ NCT05430971
ನೋಂದಣಿಯಲ್ಲಿ ಕೊನೆಯದಾಗಿ 5 Jun 2026 ರಂದು ಅಪ್ಡೇಟ್ ಮಾಡಲಾಗಿದೆ · ನಾವು 20 Oct 2026 ರಂದು ಓದಿದ್ದೇವೆ